Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension

Bisognano, John D., Bakris, George, Nadim, Mitra K., Sanchez, Luis, Kroon, Abraham A., Schafer, Jill, de Leeuw, Peter W., Sica, Domenic A.·2011·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2011.06.008

Cited by (601)

Items 101–200 of 601

  1. Detection, evaluation, and treatment of severe and resistant hypertension
    William B. White, J. Rick Turner, Domenic A. Sica, John D. Bisognano, David A. Calhoun, Raymond R. Townsend, Herbert D. Aronow, Deepak L. Bhatt, George L. Bakris · 2014 · Journal of the American Society of Hypertension
  2. Long-term chronic baroreflex activation
    Edoardo Gronda, Gino Seravalle, Fosca Quarti Trevano, Giuseppe Costantino, Andrea Casini, Ali Alsheraei, Eric G. Lovett, Emilio Vanoli, Giuseppe Mancia, Guido M. Grassi · 2015 · Journal of Hypertension
  3. Hypertension: Overly important but under-controlled
    Monique E. A. M. van Kleef, Wilko Spiering · 2017 · European Journal of Preventive Cardiology
  4. Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension
    Iliescu, Radu, Tudorancea, Ionut, Irwin, Eric D., Lohmeier, Thomas E. · 2013 · American Journal of Physiology-Heart and Circulatory Physiology
  5. Device-based Therapy for Hypertension
    Fu Liang Ng, Manish Saxena, Felix Mahfoud, Atul Pathak, Melvin David Lobo · 2016 · Current Hypertension Reports
  6. Targeting the autonomic nervous system: Measuring autonomic function and novel devices for heart failure management
    Hitesh C Patel, Stuart David Rosen, Alistair C Lindsay, Carl Hayward, Alexander Richard Lyon, Carlo Di Mario · 2013 · International Journal of Cardiology
  7. Human Dorsal Root Ganglion Stimulation Reduces Sympathetic Outflow and Long-Term Blood Pressure
    Yrsa Bergmann Sverrisdóttir, Sean Martin, George Hadjipavlou, Alexander R. Kent, David J. Paterson, James J. FitzGerald, Alexander L. Green · 2020 · JACC Basic to Translational Science
  8. Autonomic control of ventricular function in health and disease: current state of the art
    Valerie Y. H. van Weperen, Crystal M. Ripplinger, Marmar Vaseghi · 2023 · Clinical Autonomic Research
  9. Cardiac Innervation and the Autonomic Nervous System in Sudden Cardiac Death
    William A. Huang, Noel G. Boyle, Marmar Vaseghi · 2017 · Cardiac Electrophysiology Clinics
  10. Hypertension in obesity
    Michael F. Mendoza, Sergey M. Kachur, Carl J. Lavie · 2020 · Current Opinion in Cardiology
  11. Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification
    Monique E. A. M. van Kleef, Chandan M. Devireddy, Jan Van der Heyden, Mark C. Bates, George L. Bakris, Gregg W. Stone, Bryan Williams, Wilko Spiering · 2022 · JACC: Cardiovascular Interventions
  12. Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension
    Steven M. Smith, Nicholas W. Carris, Eric A. Dietrich, John G. Gums, Liz Uribe, Christopher S. Coffey, Tyler H. Gums, Barry L. Carter · 2016 · Journal of the American Society of Hypertension
  13. Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis
    Zhejia Tian, Clara Vollmer Barbosa, Hannah Lang, Johann K Bauersachs, Anette Melk, Bernhard M. W. Schmidt · 2023 · Cardiovascular Research
  14. Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system
    Manuel Wallbach, Ellen Born, Deborah Kämpfer, Stephan Lüders, Gerhard Anton Muller, Rolf Wachter, Michael Johann Koziolek · 2019 · Clinical Research in Cardiology
  15. Expert consensus: Renal denervation for the treatment of arterial hypertension
    Atul Pathak, Xavier J. Girerd, Michel Azizi, Hakim Benamer, Jean‐Michel Halimi, Pierre Lantelme, Thierry Lefèvre, Marc R. Sapoval · 2012 · Archives of cardiovascular diseases
  16. The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes
    Pupalan Iyngkaran, Namrata Sadanand Anavekar, William Majoni, Merlin C. Thomas · 2013 · Diabetes & Metabolism
  17. Baroreflex Activation: from Mechanisms to Therapy for Cardiovascular Disease
    Radu Iliescu, Ionuț Tudorancea, Thomas E. Lohmeier · 2014 · Current Hypertension Reports
  18. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the “end of the road” for renal denervation?
    Murray Epstein, Eduardo de Marchena · 2014 · Journal of the American Society of Hypertension
  19. Renal denervation for hypertension: observations and predictions of a founder
    Murray Esler · 2014 · European Heart Journal
  20. Diagnosis and management of resistant hypertension: state of the art
    Wei, Fang-Fei, Zhang, Zhen-Yu, Huang, Qi-Fang, Staessen, Jan A. · 2018 · Nature Reviews Nephrology
  21. Baroreflex Function in Cardiovascular Disease
    Husam M. Salah, RICHA GUPTA, Albert James Hicks, Kiran Mahmood, Nicholas A. Haglund, Amarinder S. Bindra, Steve Antoine, Rachel Sera García, Amin Yehya, DMITRY M. YARANOV et al. · 2024 · Journal of Cardiac Failure
  22. 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension
    Jinho Shin, Jeong Bae Park, Kwang‐Il Kim, Ju Han Kim, Dong Heon Yang, Wook Bum Pyun, Young Gweon Kim, Gheun‐Ho Kim, Shung Chull Chae · 2015 · Clinical Hypertension
  23. Baroreflex failure and beat-to-beat blood pressure variation
    Takuya Kishi · 2018 · Hypertension Research
  24. Role of Chemoreceptor Activation in Hemodynamic Responses to Electrical Stimulation of the Carotid Sinus in Conscious Rats
    Pedro L. Katayama, Jaci Ayrton Castania, Daniel Penteado Martins Dias, Kaushik P. Patel, Rubens Fazan, Hélio César Salgado · 2015 · Hypertension
  25. Management of patients with resistant hypertension: current treatment options
    Tanja Dudenbostel, Nilay Kumar, Calhoun · 2013 · Integrated Blood Pressure Control
  26. Acute on/off effects and chronic blood pressure reduction after long-term baroreflex activation therapy in resistant hypertension
    Marcel Halbach, Tilman Hickethier, Navid Madershahian, Hannes Reuter, Mathias Christoph Brandt, Uta Charlotte Hoppe, Jochen Müller‐Ehmsen · 2015 · Journal of Hypertension
  27. Blood Pressure Modulation With Low-Intensity Focused Ultrasound Stimulation to the Vagus Nerve: A Pilot Animal Study
    Ning Ji, Wan-Hua Lin, Fei Chen, Lisheng Xu, Jianping Huang, Guanglin Li · 2020 · Frontiers in Neuroscience
  28. Resistant Hypertension
    Anthony J. Viera · 2012 · The Journal of the American Board of Family Medicine
  29. Baroreflex Activation Therapy for the Treatment of Drug-Resistant Hypertension: New Developments
    Teba Alnima, Peter W. de Leeuw, Abraham A. Kroon · 2012 · Cardiology Research and Practice
  30. Renal Denervation after Symplicity HTN-3: An Update
    Alexandre Persu, Yu Jin, Fadl Elmula M. Fadl Elmula, Lotte Jacobs, Jean P. Renkin, Sverre Erik Kjeldsen · 2014 · Current Hypertension Reports
  31. Renal Responses to Long-Term Carotid Baroreflex Activation Therapy in Patients With Drug-Resistant Hypertension
    Teba Alnima, Peter W. de Leeuw, Frans E. S. Tan, Abraham A. Kroon, for the Rheos Pivotal Trial Investigators · 2013 · Hypertension
  32. Clinical Significance and Therapeutic Implication of Nocturnal Hypertension: Relationship between Nighttime Blood Pressure and Quality of Sleep
    Myeong‐Chan Cho · 2019 · Korean Circulation Journal
  33. Advances in the Pathogenesis and Treatment of Resistant Hypertension
    Jill Dybiec, Julia Krzemińska, Ewa Radzioch, Magdalena Szlagor, Magdalena Wronka, Ewelina Młynarska, Jacek Rysz, Beata Franczyk · 2023 · International Journal of Molecular Sciences
  34. Renal Responses to Chronic Suppression of Central Sympathetic Outflow
    Radu Iliescu, Eric D. Irwin, Dimitrios Georgakopoulos, Thomas E. Lohmeier · 2012 · Hypertension
  35. Pacemaker‐Mediated Programmable Hypertension Control Therapy
    Petr Neužil, Béla Péter Merkely, Andrejs Ērglis, Germanas Marinskis, Joris R. de Groot, Herwig Schmidinger, Manuel Rodríguez Venegas, Michiel Voskuil, Thomas Sturmberger, Jan Petrů et al. · 2017 · Journal of the American Heart Association
  36. Endovascular Baroreflex Amplification for Resistant Hypertension
    Monique E. A. M. van Kleef, Mark C. Bates, Wilko Spiering · 2018 · Current Hypertension Reports
  37. Baroreflex activation therapy
    Edoardo Gronda, Dárrel P. Francis, Faiez M. Zannad, Christian W. Hamm, Josép Brugada, Emilio Vanoli · 2017 · Journal of Cardiovascular Medicine
  38. Expert consensus: Renal denervation for the treatment of hypertension
    Atul Pathak, Xavier J. Girerd, Michel Azizi, Hakim Benamer, Jean‐Michel Halimi, Pierre Lantelme, Thierry Lefèvre, Marc R. Sapoval · 2012 · Diagnostic and Interventional Imaging
  39. Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation
    Thomas E. Lohmeier, Radu Iliescu · 2012 · Journal of Applied Physiology
  40. Baroreflex activation therapy in patients with prior renal denervation
    Manuel Wallbach, Marcel Halbach, Hannes Reuter, Jens Passauer, Stephan Lüders, Enrico Böhning, Dieter Zenker, Gerhard Anton Muller, Rolf Wachter, Michael Johann Koziolek · 2016 · Journal of Hypertension
  41. Baroreflex activation therapy in hypertension
    John P. Gassler, John D. Bisognano · 2014 · Journal of Human Hypertension
  42. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction
    Fred A. Weaver, William T. Abraham, William C. Little, Christian Butter, Anique Ducharme, Marcel Halbach, Didier Klug, Eric G. Lovett, Navid Madershahian, Jochen Müller‐Ehmsen et al. · 2016 · Seminars in Thoracic and Cardiovascular Surgery
  43. Baroreceptors in the carotid and hypertension—systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure
    Manuel Wallbach, Michael Johann Koziolek · 2017 · Nephrology Dialysis Transplantation
  44. Use of ambulatory blood pressure measurement in the definition of resistant hypertension: a review of the evidence
    Alexandre Persu, Eoin T O'Brien, Paolo Verdecchia · 2014 · Hypertension Research
  45. Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016
    Murray Epstein, Daniel A. Duprez · 2016 · The American Journal of Medicine
  46. Diagnosis and management of resistant hypertension
    James Peter Sheppard, Una Martin, Richard J. McManus · 2017 · Heart
  47. Design Considerations for Clinical Trials of Autonomic Modulation Therapies Targeting Hypertension and Heart Failure
    Faiez M. Zannad, Wendy Gattis Stough, Felix Mahfoud, George L. Bakris, Sverre Erik Kjeldsen, Robert S. Kieval, Hermann G. Haller, Nadim Yared, Gaetano Maria De Ferrari, Ileana L. Piña et al. · 2014 · Hypertension
  48. Non-clinical and Pre-clinical Testing to Demonstrate Safety of the Barostim Neo Electrode for Activation of Carotid Baroreceptors in Chronic Human Implants
    Seth J. Wilks, Seth A. Hara, Erika K. Ross, Evan N. Nicolai, Paul A. Pignato, Adam W. Cates, Kip A. Ludwig · 2017 · Frontiers in Neuroscience
  49. Pacemaker‐Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot Study
    Zbigniew F. Kalarus, Béla Péter Merkely, Petr Neužil, Marcin Grabowski, Przemyslaw P. Mitkowski, Germanas Marinskis, Andrejs Ērglis, Jarosław Kaźmierczak, Thomas Sturmberger, Adam Sokal et al. · 2021 · Journal of the American Heart Association
  50. Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction
    Ahmet Afşin Oktay, Sanjiv Jayendra Shah · 2014 · Current Cardiology Reports
  51. Global- and Renal-Specific Sympathoinhibition in Aldosterone Hypertension
    Thomas E. Lohmeier, Boshen Liu, Drew A. Hildebrandt, Adam W. Cates, Dimitrios Georgakopoulos, Eric D. Irwin · 2015 · Hypertension
  52. Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor Modulation
    Karsten Heusser, Arvo Thöne, Axel Lipp, Jan Menne, Joachim Beige, Hannes Reuter, Fabian Hoffmann, Marcel Halbach, Siegfried Eckert, Manuel Wallbach et al. · 2019 · Hypertension
  53. Dysfunctional Brain-bone Marrow Communication: A Paradigm Shift in the Pathophysiology of Hypertension
    Monica M. Santisteban, Jasenka A Zubcevic, David Mark Baekey, Mohan K. Raizada · 2013 · Current Hypertension Reports
  54. Resistant hypertension: a practical clinical approach
    Elizabeth Silaid Muxfeldt, Fábio de Souza, Gil Fernando Salles · 2013 · Journal of Human Hypertension
  55. Autonomic modulation of ventricular electrical activity: recent developments and clinical implications
    Valerie Y. H. van Weperen, Marc A. Vos, Olujimi Adeoluwa Ajijola · 2021 · Clinical Autonomic Research
  56. Nondrug Interventions for Treatment of Hypertension
    Kevin J. Woolf, John D. Bisognano · 2011 · Journal of Clinical Hypertension
  57. Chronic Deep Brain Stimulation Decreases Blood Pressure and Sympathetic Nerve Activity in a Drug- and Device-Resistant Hypertensive Patient
    Erin L. O’Callaghan, Emma C. Hart, Hugh P. Sims-Williams, Shazia Javed, Amy E. Burchell, MARK PAPOUCHADO, Jens Tank, Karsten Heusser, Jens Jordan, Jan Menne et al. · 2017 · Hypertension
  58. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension
    Raven A. Voora, Alan L. Hinderliter · 2018 · Current Hypertension Reports
  59. Novedades en hipertensión arterial y diabetes mellitus
    Alberto Cordero, Lorenzo Fácila, Enrique Galve, Pilar Mazón · 2010 · Revista Española de Cardiología
  60. Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings
    Oleg Borisenko, Joachim Beige, Eric G. Lovett, Uta Charlotte Hoppe, Staffan Bjessmo · 2013 · Journal of Hypertension
  61. Baroreflex activation therapy in patients with pre-existing implantable cardioverter-defibrillator: compatible, complementary therapies
    Navid Madershahian, Maximilian Philipp Scherner, Jochen Müller‐Ehmsen, Marcel Halbach, Tilman Hickethier, Ralf Velden, Yeong‐Hoon Choi, Jens Wippermann, Thorsten Wahlers · 2014 · EP Europace
  62. Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
    Juan Carlos Yugar‐Toledo, Heitor Moreno, Miguel Gus, Guido Bernardo Aranha Rosito, Luíz Cesar Nazário Scala, Elizabeth Silaid Muxfeldt, Alexandre Alessi, Andréa Araújo Brandão, Osni Moreira Filho, Audes D. M. Feitosa et al. · 2020 · Arquivos Brasileiros de Cardiologia
  63. When blood pressure refuses to budge: exploring the complexity of resistant hypertension
    Meeti Keyur Champaneria, R. Patel, Terry L Oroszi · 2023 · Frontiers in Cardiovascular Medicine
  64. Upregulation of the Renin‐Angiotensin‐Aldosterone‐Ouabain System in the Brain Is the Core Mechanism in the Genesis of All Types of Hypertension
    Hakuo Takahashi · 2012 · International Journal of Hypertension
  65. Central Angiotensin-II Increases Blood Pressure and Sympathetic Outflow via Rho Kinase Activation in Conscious Rabbits
    Peter Ricci Pellegrino, Alicia M. Schiller, Karla Haack, Irving H. Zucker · 2016 · Hypertension
  66. Systemic vascular effects of acute electrical baroreflex stimulation
    Steven Burgoyne, Dimitrios Georgakopoulos, Israel Belenkie, John V. Tyberg · 2014 · American Journal of Physiology-Heart and Circulatory Physiology
  67. Carotid Baroreceptor Stimulation Prevents Arrhythmias Induced by Acute Myocardial Infarction Through Autonomic Modulation
    Kai Liao, Lilei Yu, Bo He, Bing S Huang, Kang Yang, Gaowa Saren, Songyun Wang, Xiaoya Zhou, Hong Jiang · 2014 · Journal of Cardiovascular Pharmacology
  68. An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems
    Rolf Wachter, Marcel Halbach, George L. Bakris, John D. Bisognano, Hermann G. Haller, Joachim Beige, Abraham A. Kroon, Mitra K. Nadim, Eric G. Lovett, Jill E. Schafer et al. · 2016 · Journal of the American Society of Hypertension
  69. Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis
    Lucas Lauder, Bruno R. da Costa, Sebastian Ewen, Sean Selim Scholz, William C. Wijns, Thomas Felix Lüscher, Patrick W.J.C. Serruys, Elazer Reuven Edelman, Davide Capodanno, Michael Böhm et al. · 2020 · European Heart Journal
  70. Emerging drugs for the treatment of diabetic nephropathy
    Yoon Kook Kim, Xinyuan Ning, Kashif M. Munir, Stephen N. Davis · 2022 · Expert Opinion on Emerging Drugs
  71. The role of low-level vagus nerve stimulation in cardiac therapy
    Yuhong Wang, Sunny S. Po, Benjamin J. Scherlag, Lilei Yu, Hong Jiang · 2019 · Expert Review of Medical Devices
  72. Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension
    Eline H. Groenland, Wilko Spiering · 2020 · Current Hypertension Reports
  73. Carotid Baroreceptor Activation for the Treatment of Resistant Hypertension and Heart Failure
    Michael N. Doumas, Charles J. Faselis, Costas P. Tsioufis, Vasilios Papademetriou · 2012 · Current Hypertension Reports
  74. Low-Level Carotid Baroreceptor Stimulation Suppresses Ventricular Arrhythmias during Acute Ischemia
    Kai Liao, Lilei Yu, Kang Yang, Gaowa Saren, Songyun Wang, Bing S Huang, Hong Jiang · 2014 · PLoS ONE
  75. Baroreflex Activation Therapy Lowers Arterial Pressure Without Apparent Stimulation of the Carotid Bodies
    Teba Alnima, Emilie J.B.M. Goedhart, Randy Seelen, Chris P.M. van der Grinten, Peter W. de Leeuw, Abraham A. Kroon · 2015 · Hypertension
  76. Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy
    Joachim Beige, T Jentzsch, Ralph T. Wendt, G. Hennig, Michael Johann Koziolek, Manuel Wallbach · 2017 · Journal of Hypertension
  77. Treatment of Hypertension: A Review
    Laxmi Narayan Goit, Shaning Yang · 2019 · Yangtze Medicine
  78. Resistant hypertension: consensus document from the Korean society of hypertension
    Sungha Park, Jinho Shin, Sang‐Hyun Ihm, Kwang‐Il Kim, Hack‐Lyoung Kim, Hyeon Chang Kim, Eun Mi Lee, Jang Hoon Lee, Shin Young Ahn, Eun Joo Cho et al. · 2023 · Clinical Hypertension
  79. Stimulation of Angiotensin Type 1A Receptors on Catecholaminergic Cells Contributes to Angiotensin-Dependent Hypertension
    Nikola Jancovski, Jaspreet K. Bassi, David A. Carter, Yan‐Ting Choong, Angela A. Connelly, Thu-Phuc Nguyen, Daian Chen, Elena V. Lukoshkova, Clément Menuet, Geoffrey A. Head et al. · 2013 · Hypertension
  80. Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison
    Martin J. Wolley, Michael Stowasser · 2016 · Current Hypertension Reports
  81. Baroreflex stimulation attenuates central but not peripheral inflammation in conscious endotoxemic rats
    Fernanda Brognara, Jaci Ayrton Castania, Daniel Penteado Martins Dias, Alexandre H. Lopes, Rubens Fazan, Alexandre Kanashiro, Luis Ulloa, Hélio César Salgado · 2018 · Brain Research
  82. Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertension
    Manuel Wallbach, Enrico Böhning, Luca-Yves Lehnig, Charlotte Schroer, Gerhard Anton Muller, Rolf Wachter, Stephan Lüders, Dieter Zenker, Michael Johann Koziolek · 2018 · Journal of Hypertension
  83. Novel Approach to Elucidate Human Baroreflex Regulation at the Brainstem Level: Pharmacological Testing During fMRI
    Darius A. Gerlach, Jorge Manuel, Alex Hoff, Hendrik Kronsbein, Fabian Hoffmann, Karsten Heusser, Heimo Ehmke, André Diedrich, Jens Jordan, Jens Tank et al. · 2019 · Frontiers in Neuroscience
  84. Neural modulation for hypertension and heart failure
    Sakima Ahmad Smith, Patrick Rossignol, Shannon Willis, Faiez M. Zannad, Robert John Mentz, Stuart Pocock, John D. Bisognano, Y. Nadim, Nancy L. Geller, Stephen B. Ruble et al. · 2016 · International Journal of Cardiology
  85. Electrical carotid sinus stimulation in treatment resistant arterial hypertension
    Jens Jordan, Karsten Heusser, Julia Brinkmann, Jens Tank · 2012 · Autonomic Neuroscience
  86. Recent advances in understanding and managing resistant/refractory hypertension
    Michael N. Doumas, Konstantinos P. Imprialos, Manolis S. Kallistratos, Athanasios John Manolis · 2020 · F1000Research
  87. Rethinking Resistant Hypertension
    Gabrielle Bourque, Swapnil S. Hiremath · 2022 · Journal of Clinical Medicine
  88. Copeptin is increased in resistant hypertension
    Mendes, Margarida, Dubourg, Julie, Blanchard, Anne, Bergerot, Damien, Courand, Pierre-Yves, Forni, Valentina, Frank, Michael, Bobrie, Guillaume, Menard, Joel, Azizi, Michel · 2016 · Journal of Hypertension
  89. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure
    Gisele Lopes Cavalcante, Fernanda Brognara, Lucas Vaz de Castro Oliveira, Renata Maria Lataro, M Durand, Aldeídia Pereira de Oliveira, Antônio Cláudio Lucas da Nóbrega, Hélio César Salgado, João Paulo J. Sabino · 2021 · Acta Physiologica
  90. Endovascular baroreflex amplification and the effect on sympathetic nerve activity in patients with resistant hypertension: A proof-of-principle study
    Monique E. A. M. van Kleef, Karsten Heusser, André Diedrich, P. Liam Oey, Jens Tank, Jens Jordan, Peter J. Blankestijn, Bryan Williams, Wilko Spiering · 2021 · PLoS ONE
  91. Neuromodulation devices for heart failure
    Veronica Dusi, Filippo Angelini, Michael R. Zile, Gaetano Maria De Ferrari · 2022 · European Heart Journal Supplements
  92. Regulation of Renin Secretion and Arterial Pressure During Prolonged Baroreflex Activation
    Drew A. Hildebrandt, Eric D. Irwin, Adam W. Cates, Thomas E. Lohmeier · 2014 · Hypertension
  93. Emerging concepts for patients with treatment-resistant hypertension
    Alfonso Eirin, Stephen C. Textor, Lilach O. Lerman · 2016 · Trends in Cardiovascular Medicine
  94. Solving Baroreceptor Mystery: Role of PIEZO Ion Channels
    Suzanne D. Burke, Jens Jordan, David Glenn Harrison, S. Ananth Karumanchi · 2019 · Journal of the American Society of Nephrology
  95. Effect of Cardiac-Cycle-Synchronized Selective Vagal Stimulation on Heart Rate and Blood Pressure in Rats
    Dennis T. T. Plachta, Josef Zentner, Debora Aguirre, Oscar F. Cota, Thomas Stieglitz, Mortimer Gierthmuehlen · 2016 · Advances in Therapy
  96. Angiotensin II Infusion Model of Hypertension
    Thomas E. Lohmeier · 2012 · Hypertension
  97. The Baroreflex in Hypertension
    Genaro Fernandez, Junsoo Alex Lee, Lynn C. Liu, John P. Gassler · 2015 · Current Hypertension Reports
  98. Resistant Hypertension: Diagnosis and Management
    Nagalakshmi Nagarajan, Diana I. Jalal · 2019 · Advances in Chronic Kidney Disease
  99. Treatment Resistant Hypertension
    Franz Weber, Manfred Anlauf · 2014 · Deutsches Ärzteblatt international
  100. Long-term effects of baroreflex activation therapy on glucose metabolism
    Manuel Wallbach, Luca-Yves Lehnig, Hans‐Joachim Helms, Charlotte Schroer, Gerhard Anton Muller, Rolf Wachter, Michael Johann Koziolek · 2014 · Acta Diabetologica